Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Silence Therapeutics
Silence Therapeutics
Another biotech shuffles its C-suite as Silence CEO steps down
Endpoints
Tue, 02/22/22 - 10:54 am
Silence Therapeutics
Pharma CEOs
RNAi
Silence Therapeutics, Hansoh partner to develop novel siRNA therapeutics
Pharmaceutical Business Review
Mon, 10/18/21 - 11:06 am
Silence Therapeutics
Hansoh Pharmaceutical
mRNAi
siRNA
drug development
AstraZeneca-partnered RNA player Silence plans Nasdaq listing
Fierce Biotech
Wed, 05/20/20 - 10:45 am
Silence Therapeutics
RNA therapeutics
RNA
NASDAQ
AstraZeneca
gene silencing
Silence Therapeutics Says Collaborating With Astrazeneca On siRNA Therapeutics
Reuters
Wed, 03/25/20 - 10:34 am
Silence Therapeutics
AstraZeneca
siRNA
drug development
cardiovascular disease
renal disease
respiratory disease
metabolic disorders
EuroBiotech Report: Brexit, BioNTech success, GlaxoSmithKline inks AI deal, Silence takes Alnylam to court and Shire makes cuts
Fierce Biotech
Thu, 07/6/17 - 05:58 pm
Europe
biotech
Brexit
BioNTech
GSK
artificial intelligence
Sanofi
Exscientia
Silence Therapeutics
RNAi
Silence Therapeutics raises $58 million to advance R&D
BioPharma Dive
Thu, 04/9/15 - 03:12 pm
Silence Therapeutics
RNAi
R&D
Quark Pharma extends pact with Pfizer to develop compounds containing Silence’s AtuRNAi
Pharmabiz
Sat, 05/5/12 - 04:38 pm
Pfizer
Quark Pharmaceuticals
Silence Therapeutics
PF-655
Open-Angle Glaucoma
diabetic macular oedema
AtuRNAi